S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.67 (-1.75%)
MSFT   416.22 (+0.62%)
META   501.57 (+0.27%)
GOOGL   154.94 (+0.05%)
AMZN   183.81 (+0.10%)
TSLA   156.61 (-3.02%)
NVDA   877.45 (+2.03%)
AMD   163.57 (+2.03%)
NIO   3.85 (-1.03%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.98 (+0.50%)
GE   156.75 (+1.98%)
CGC   6.80 (-2.58%)
DIS   114.03 (+0.96%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.17 (-0.43%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.67 (-1.75%)
MSFT   416.22 (+0.62%)
META   501.57 (+0.27%)
GOOGL   154.94 (+0.05%)
AMZN   183.81 (+0.10%)
TSLA   156.61 (-3.02%)
NVDA   877.45 (+2.03%)
AMD   163.57 (+2.03%)
NIO   3.85 (-1.03%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.98 (+0.50%)
GE   156.75 (+1.98%)
CGC   6.80 (-2.58%)
DIS   114.03 (+0.96%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.17 (-0.43%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.67 (-1.75%)
MSFT   416.22 (+0.62%)
META   501.57 (+0.27%)
GOOGL   154.94 (+0.05%)
AMZN   183.81 (+0.10%)
TSLA   156.61 (-3.02%)
NVDA   877.45 (+2.03%)
AMD   163.57 (+2.03%)
NIO   3.85 (-1.03%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.98 (+0.50%)
GE   156.75 (+1.98%)
CGC   6.80 (-2.58%)
DIS   114.03 (+0.96%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.17 (-0.43%)
S&P 500   5,072.85 (+0.22%)
DOW   37,937.90 (+0.54%)
QQQ   432.57 (+0.35%)
AAPL   169.67 (-1.75%)
MSFT   416.22 (+0.62%)
META   501.57 (+0.27%)
GOOGL   154.94 (+0.05%)
AMZN   183.81 (+0.10%)
TSLA   156.61 (-3.02%)
NVDA   877.45 (+2.03%)
AMD   163.57 (+2.03%)
NIO   3.85 (-1.03%)
BABA   69.96 (-0.93%)
T   16.04 (-1.23%)
F   12.18 (-0.41%)
MU   121.98 (+0.50%)
GE   156.75 (+1.98%)
CGC   6.80 (-2.58%)
DIS   114.03 (+0.96%)
AMC   2.78 (+12.55%)
PFE   25.80 (-0.42%)
PYPL   63.76 (+0.39%)
XOM   119.17 (-0.43%)

BioNTech (BNTX) SEC Filings & 10K Form

$86.68
-1.21 (-1.38%)
(As of 03:09 PM ET)

Recent BioNTech SEC Filings

DateFilerForm TypeView
04/08/2024
4:05 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
6:12 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
6:57 AM
BioNTech (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/20/2024
6:33 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/20/2024
6:11 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
8:04 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
7:41 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
5:26 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
6:26 AM
BioNTech (Subject)
Medine GmbH (Filed by)
Form SC 13G/A
02/08/2024
5:08 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/07/2024
4:03 PM
ATHOS KG (Filed by)
BioNTech (Subject)
Form SC 13G/A
01/31/2024
6:47 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2024
8:14 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/09/2024
6:01 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/04/2024
7:02 AM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/18/2023
3:22 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/07/2023
7:17 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2023
7:03 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2023
5:52 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/06/2023
5:54 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/23/2023
3:16 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2023
5:03 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2023
5:14 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2023
4:35 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144/A
09/29/2023
4:11 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
4:18 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144/A
08/14/2023
7:34 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2023
7:02 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/07/2023
5:06 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2023
7:12 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/29/2023
3:52 PM
BioNTech (Subject)
Jeggle Helmut Wolfgang (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/29/2023
6:09 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2023
4:20 PM
ATHOS KG (Reporting)
BioNTech (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2023
4:26 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/23/2023
3:41 PM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2023
7:48 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2023
7:51 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2023
6:43 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2023
8:22 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2023
5:56 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/08/2023
5:53 AM
BioNTech (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Your eBook: Mastering Earnings Announcements Trading (Ad)

Trading around earnings announcements (Pre-Earnings, Into-Earnings, and Post-Earnings) provides a unique trading opportunity. That is because trading around earnings announcements presents short-term trading opportunities (these are great because they don’t tie your money up for very long).

Click Here to Claim Your FREE The Ultimate Strategy Guide To Trade Earnings E-Book .
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BNTX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners